<DOC>
	<DOC>NCT02824380</DOC>
	<brief_summary>An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects with Androgenic Alopecia.</brief_summary>
	<brief_title>Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Male, aged between 19 and 65 years, clinically healthy BMI between 18.5kg/m2 and 27kg/m2 Clinical history of Androgenic Alopecia Subject has any dermatological disorders of the scalp Subject has a history of hair transplants, hair weaves Subject has hypersensitivity to previously prescribed minoxidil or finasteride Subject who is considered inappropriate to participate in the study due to any conditions including screening results at the investigator's discretion</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>